Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Augmented Infant Resuscitator (AIR) is an inexpensive add-on, compatible with nearly every existing bag-valve mask and many types of ventilation equipment. AIR monitors ventilation quality and provides real-time objective feedback and actionable cues to clinicians to both shorten training times and improve resuscitation quality, adoption, retention, and confidence.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Augmented Infant Resuscitator to Enhance Newborn Ventilation

NCT04820504

Asphyxia Neonatorum Birth Asphyxia Perinatal Asphyxia

COMPLETED NA

Ventilation Knowledge and Skills Retention Using a Novel Tool, the Augmented Infant Resuscitator (AIR) Device as an Instant-feedback Tool

NCT04889001

Ventilation Skills Acquisition and Retention Ventilation Knowledge Acquisition and Retention

UNKNOWN NA

Augmented Reality to Support Cardiopulmonary Resuscitation

NCT06376643

Cardiopulmonary Arrest Resuscitation Pediatric

COMPLETED NA

Investigation of a Novel Turbine-driven Ventilator for Use in Cardiopulmonary Resuscitation

NCT02743299

Cardiac Arrest Hyperventilation

COMPLETED EARLY_PHASE1

Noncontact, Handheld Device for Measurement of Respiratory Rate

NCT04215887

Children

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators propose a randomized controlled trial to asses the impact, feasibility, and acceptability of real-time visual feedback from the AIR device. The study will begin by training and equipping all available skilled birth attendants (SBAs) at the participating facilities in the Helping Babies Breathe (HBB) training curriculum. SBAs will also receive HBB Provider Guides and wall-mountable HBB action plans. Immediately before and after training, the study teams will use the traditional HBB assessment tools to evaluate SBAs' HBB knowledge and skills.

Facilities will then be randomized, by cluster, to either receive AIR feedback at the start of the trial (Cohort A) or beginning at 2 (Cohort B) or 4 months post-training (Cohort C). Both intervention and control cohorts will be encouraged to start regular "low-dose, high-frequency" (LDHF) practice with the AIR devices. LDHF involves frequent "doses" of shorter, often skills- or competency-based, individual- or pair-learning practice sessions. Study teams will establish HBB practice corners in each health facility, consisting of HBB equipment, NeoNatalie, AIR device, HBB Action Plan, and a log book.

Participants in Cohort A will practice with AIR devices providing visual feedback immediately post-training, while Cohorts B and C will start with AIR devices without visual feedback. Disabling feedback from the device does not compromise its recording function that collects time-stamped data on ventilation quality. Cohort B will switch to AIR device feedback at 2 months, and Cohort C will switch to AIR device feedback at 4 months. All cohorts will continue LDHF practice with AIR device feedback through up to 6 months after initial HBB training.

During the study, the study teams will conduct facility-based bag-mask ventilation (BMV) assessments at 2, 4, and 6 months. The primary outcome for this measurement will be duration of effective ventilation in a two-minute window after initiation of ventilation, as part of the HBB program's existing BMV skills check and OSCE B. "Effective ventilation" is defined as ventilating in the correct rate range without airway blockages, significant leaks, and harsh breaths and will be determined by the AIR device. Note, during these skills assessments, study participants will be evaluated with feedback turned off during the two-minute breathing epoch.

After AIR feedback is turned on at a facility, de-identified device-recorded data on provider-level frequency and quality of practice will be aggregated, shared, and discussed with each health center every 2 months to support and harmonize with their existing facility-led quality improvement efforts.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asphyxia Neonatorum Birth Asphyxia Perinatal Asphyxia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort A

Receives AIR device feedback beginning immediately after training

Group Type EXPERIMENTAL

Augmented Infant Resuscitator (AIR)

Intervention Type DEVICE

Real-time visual feedback from the AIR device regarding quality of bag-mask ventilation

Cohort B

Receives AIR device feedback beginning 2 months after training

Group Type EXPERIMENTAL

Augmented Infant Resuscitator (AIR)

Intervention Type DEVICE

Real-time visual feedback from the AIR device regarding quality of bag-mask ventilation

Cohort C

Receives AIR device feedback beginning 4 months after training

Group Type EXPERIMENTAL

Augmented Infant Resuscitator (AIR)

Intervention Type DEVICE

Real-time visual feedback from the AIR device regarding quality of bag-mask ventilation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Augmented Infant Resuscitator (AIR)

Real-time visual feedback from the AIR device regarding quality of bag-mask ventilation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Skilled birth attendants (SBAs) working clinically at the selected facilities (i.e., in-service providers)
* SBAs who participate in the HBB training offered by our group at the beginning of the study
* SBAs who demonstrate competence, after initial training, in key neonatal resuscitation skills and competencies (i.e., pass the BMV skills check and OSCE B)
* SBAs able to adequately understand the language in which the HBB training is offered (e.g., the investigators anticipate the trainings will be offered in English)
* SBAs over 18 years of age
* SBAs who provide written informed consent for participation in the study

Exclusion Criteria

* Students or clinicians still in training (i.e., pre-service providers)
* SBAs and other health workers who do not participate in initial HBB training
* SBAs that are unable to adequately understand the language in which the HBB training is offered
* SBAs under 18 years of age
* SBAs who do not provide written informed consent for participation in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes